Fortive Corporation Revenue 2014–2025
Fortive Corporation reported $4.16B of revenue for fiscal 2025. That was 33.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -10.3%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $4.16B | -33.3% |
| FY 2024 | $6.23B | +2.7% |
| FY 2023 | $6.07B | +4.1% |
| FY 2022 | $5.83B | +10.9% |
| FY 2021 | $5.25B | +13.4% |
| FY 2020 | $4.63B | +1.5% |
| FY 2019 | $4.56B | -29.3% |
| FY 2018 | $6.45B | +12.1% |
| FY 2017 | $5.76B | +7.0% |
| FY 2016 | $5.38B | -13.0% |
| FY 2015 | $6.18B | -2.5% |
| FY 2014 | $6.34B | — |
Source: Fortive Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open FTV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Fortive Corporation reported $4.16B of revenue for fiscal 2025. That was 33.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -10.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Fortive Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeFortive Corporation — frequently asked questions
What is Fortive Corporation's revenue?
Fortive Corporation (FTV) reported revenue of $4.16B for fiscal year 2025, per its SEC filings.
How has Fortive Corporation's revenue changed over time?
Between fiscal 2014 and 2025, FTV's revenue declined at roughly 3.8% per year (compound annual rate), from $6.34B to $4.16B.
Where does this data come from?
Figures are computed from Fortive Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.